Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 21301380)

Published in Pharmacogenet Genomics on May 01, 2011

Authors

Hye-Ryun Kang1, Young Koo Jee, Yon-Soo Kim, Chang Hwa Lee, Jae-Woo Jung, Sae Hoon Kim, Heung-Woo Park, Yoon-Seok Chang, In-Jin Jang, Sang-Heon Cho, Kyung-Up Min, Sang-Heon Kim, Kyung Wha Lee, Adverse Drug Reaction Research Group in Korea

Author Affiliations

1: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Articles citing this

Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clin Pharmacol Ther (2012) 1.72

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ (2015) 1.52

The genetics of hyperuricaemia and gout. Nat Rev Rheumatol (2012) 1.47

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet (2011) 1.24

Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J Allergy Clin Immunol (2015) 1.03

Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pac Allergy (2013) 1.01

Testing for drug hypersensitivity syndromes. Clin Biochem Rev (2013) 1.00

Racial and gender disparities among patients with gout. Curr Rheumatol Rep (2013) 0.98

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms. Asia Pac Allergy (2015) 0.98

Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract (2014) 0.96

Genotyping for severe drug hypersensitivity. Curr Allergy Asthma Rep (2014) 0.92

Clinical applications of drug desensitization in the Asia-Pacific region. Asia Pac Allergy (2011) 0.84

An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing. Genet Med (2015) 0.83

HLA and Disease Associations in Koreans. Immune Netw (2011) 0.82

PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics. Pharmacogenet Genomics (2014) 0.82

Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Semin Arthritis Rheum (2016) 0.81

Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol (2015) 0.81

Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol (2015) 0.80

Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions. Comb Chem High Throughput Screen (2015) 0.80

The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics (2017) 0.80

Sorafenib induces delayed-onset cutaneous hypersensitivity: a case series. Allergy Asthma Immunol Res (2014) 0.78

HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand. Front Pharmacol (2016) 0.78

HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs. Yonsei Med J (2016) 0.78

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B. Pharmacogenet Genomics (2015) 0.76

Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. Korean J Intern Med (2015) 0.76

Recent advances in understanding and managing gout. F1000Res (2017) 0.75

Genome-wide approaches (GWA) in oral and craniofacial diseases research. Oral Dis (2012) 0.75

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies. Oncotarget (2016) 0.75

Recent advances in the understanding of severe cutaneous adverse reactions. Br J Dermatol (2017) 0.75

Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol (2017) 0.75

Articles by these authors

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol (2007) 2.71

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol (2006) 2.69

Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol (2012) 2.05

Biological removal of polychlorinated dibenzo-p-dioxins from incinerator fly ash by Sphingomonas wittichii RW1. Water Res (2005) 2.02

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. CMAJ (2006) 2.01

Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol (2009) 1.79

Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J (2012) 1.78

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis (2012) 1.76

Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol (2007) 1.60

Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum (2004) 1.57

Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transplant (2009) 1.54

Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Respirology (2010) 1.51

Ubiquitous healthcare service using Zigbee and mobile phone for elderly patients. Int J Med Inform (2008) 1.50

The reality of an intermediate type between asthma and COPD in practice. Respir Care (2012) 1.48

Prognostic factors affecting anatomic outcome of rotator cuff repair and correlation with functional outcome. Arthroscopy (2008) 1.45

A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet (2003) 1.40

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers. Clin Pharmacol Ther (2005) 1.35

Epidemiologic and clinical features of anaphylaxis in Korea. Ann Allergy Asthma Immunol (2008) 1.35

Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ Health Perspect (2009) 1.34

The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol (2009) 1.33

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. Br J Clin Pharmacol (2008) 1.33

Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis (2009) 1.32

Treatment of distal clavicle fracture: a systematic review of treatment modalities in 425 fractures. Arch Orthop Trauma Surg (2010) 1.31

HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Pharmacogenomics (2010) 1.31

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res (2011) 1.28

MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23

Arthroscopic repair of massive rotator cuff tears: outcome and analysis of factors associated with healing failure or poor postoperative function. Am J Sports Med (2013) 1.23

A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives. Asia Pac Allergy (2013) 1.21

Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med (2011) 1.20

Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care (2010) 1.20

Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers. J Clin Pharmacol (2012) 1.19

Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp Mol Med (2002) 1.18

TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. J Allergy Clin Immunol (2007) 1.16

Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology (2012) 1.15

Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum (2010) 1.14

Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology (2002) 1.13

Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers. Pharmacoepidemiol Drug Saf (2009) 1.13

HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency. Nephrol Dial Transplant (2011) 1.10

Evaluation of intravenous midazolam limited sampling models to determine area under the concentration time curve during cytochrome P450 3A baseline, inhibition and induction or activation. Int J Clin Pharmacol Ther (2012) 1.09

Low-dose persistent organic pollutants increased telomere length in peripheral leukocytes of healthy Koreans. Mutagenesis (2010) 1.09

STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism. J Immunol (2005) 1.09

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states. Clin Pharmacol Ther (2004) 1.08

Passive air sampling of polychlorinated biphenyls and organochlorine pesticides at the Korean Arctic and Antarctic research stations: implications for long-range transport and local pollution. Environ Sci Technol (2008) 1.08

Biotransformation of 2,7-dichloro- and 1,2,3,4-tetrachlorodibenzo-p-dioxin by Sphingomonas wittichii RW1. Appl Environ Microbiol (2002) 1.07

Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS One (2010) 1.06

Factors affecting rotator cuff healing after arthroscopic repair: osteoporosis as one of the independent risk factors. Am J Sports Med (2011) 1.05

Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell (2011) 1.05

Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea. Eur J Radiol (2010) 1.05

Reliability of the grading system for fatty degeneration of rotator cuff muscles. Clin Orthop Relat Res (2009) 1.04

The financial burden of asthma: a nationwide comprehensive survey conducted in the republic of Korea. Allergy Asthma Immunol Res (2010) 1.04

Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob Agents Chemother (2009) 1.04

Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther (2005) 1.04

Allergic diseases and air pollution. Asia Pac Allergy (2013) 1.03

Factors affecting the distribution of the rate of carbon uptake by forests in South Korea. Environ Sci Technol (2004) 1.03

Correlation between the Korean version of Asthma Control Test and health-related quality of life in adult asthmatics. J Korean Med Sci (2008) 1.03

HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol (2004) 1.03

Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J Allergy Clin Immunol (2007) 1.03

Influence of a municipal solid waste incinerator on ambient air and soil PCDD/Fs levels. Chemosphere (2006) 1.02

Moderate preoperative shoulder stiffness does not alter the clinical outcome of rotator cuff repair with arthroscopic release and manipulation. Arthroscopy (2008) 1.02

A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trial. Anesth Analg (2002) 1.01

Increase in carbon emissions from forest fires after intensive reforestation and forest management programs. Sci Total Environ (2006) 1.00

Voriconazole-associated severe hyponatremia. Med Mycol (2011) 1.00

Haplotype structure and allele frequencies of CYP2B6 in a Korean population. Drug Metab Dispos (2004) 0.99